Epigral Limited
EPIGRAL.BO
Get informed when a big investor buys or sells
+ FollowMarket Cap$43.12B
Close$
$274.93
72.4% downside
Current Fair Value
72.4% downsideOvervalued by 72.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $43.12 Billion |
|---|---|
| Enterprise Value | $43.12 Billion |
| Dividend Yield | $5.00 (0.50%) |
| Earnings per Share | $76.95 |
| Beta | 0.21 |
| Outstanding Shares | 43,141,338 |
Return
| Return on Equity | 12.20% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 15.77 |
|---|---|
| PEG | -41.58 |
| Price to Sales | 1.64 |
| Price to Book Ratio | 1.94 |
| Enterprise Value to Revenue | 1.64 |
| Enterprise Value to EBIT | 10.3 |
| Enterprise Value to Net Income | 15 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 27, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$7.05 B
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$6.84 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Epigral Limited
1,135 employees
CEO: Kaushal Ashisbhai Soparkar Epigral Limited, an Ahmedabad, India-headquartered company founded in 2007, manufactures and distributes chlor-alkali chemicals and their related derivatives both domestically and internationally. The company's product portfolio includes...